Archive

New Marker of Cardiovascular Risk Discovered in T2D
New Marker of Cardiovascular Risk Discovered in T2D A significant quantity of dysfunctional monocytes appears to indicate poor cardiovascular prognosis in patients with type 2 diabetes.


New Score Predicts Risk for Death on Heart Transplant List
New Score Predicts Risk for Death on Heart Transplant List Allocation score, called the US candidate risk score (US-CRS), outperformed the current therapy-based 6-status system in rank ordering heart transplant candidates by medical urgency.


Near-Death Experiences During CPR: An Impetus for Better Care
Near-Death Experiences During CPR: An Impetus for Better Care If someone has been in cardiac arrest for 10 minutes, the brain is permanently damaged and there's nothing to do, right? Not so according to emerging evidence that suggests that the brain shows signs of electrical recovery for as long as an hour into ongoing cardiopulmonary resuscitation (CPR). This time between cardiac arrest and awakening can be a period of vivid experiences for the dying patient before they return to life — a phenomenon known as "recalled death."


Novel Biomarkers for Aortic Stenosis Identified
Novel Biomarkers for Aortic Stenosis Identified A new analysis that used plasma proteomics, cardiac imaging, and event surveillance of participants in a longitudinal cohort study identified 52 circulating proteins with significant links to aortic valve (AV) hemodynamics and the risk for AV-related hospitalizations. Two of these biomarkers had particularly robust associations.


Recommendations for magnetic resonance imaging in patients with cardiac implantable electronic devices
Recommendations for magnetic resonance imaging in patients with cardiac implantable electronic devices Over the last several decades, magnetic resonance (MR) imaging has become the diagnostic modality of choice for several conditions, cardiac and non-cardiac. However, MR uses a static magnetic field, gradient magnetic fields and pulsed radiofrequency energy, all of which may interact with metallic and electronic components within the field. As such, patients with cardiac implantable electronic devices (CIEDs) have traditionally been precluded from MR imaging given the potential harm from mechanical force and torque, heating and tissue damage, unwanted myocardial stimulation or electrical reset.


Cancer Identified as a New Cardiovascular Risk Factor
Cancer Identified as a New Cardiovascular Risk Factor A history of cancer is an independent predictor of major cardiovascular events in patients undergoing coronary angioplasty. Cancer should be considered a new cardiovascular risk factor in primary and secondary prevention.


Management of arrhythmogenic right ventricular cardiomyopathy
Management of arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a disease characterised by fibrofatty replacement of the ventricular myocardium due to specific mutations, leading to ventricular arrhythmias and sudden cardiac death. Treating this condition can be challenging due to progressive fibrosis, phenotypic variations and small patient cohorts limiting the feasibility of conducting meaningful clinical trials.


Mortality Still Significant in High-Risk PE Despite Advances
Mortality Still Significant in High-Risk PE Despite Advances 1 in 5 patients with high-risk pulmonary embolism (PE) and more than 2 in 5 with catastrophic PE with hemodynamic collapse die in the hospital, a large contemporary analysis showed.


ECG Deep-Learning Algorithm Predicts Mortality Post Surgery
ECG Deep-Learning Algorithm Predicts Mortality Post Surgery Algorithm interpreting preoperative ECGs can identify risk for postoperative death in those undergoing cardiac surgery, noncardiac surgery, and interventional procedures, a large new study showed. The algorithm was more effective in identifying high-risk patients who went on to experience postoperative mortality than a widely used risk tool.


FDA Approves First Pulsed Field Ablation System for AF
FDA Approves First Pulsed Field Ablation System for AF The US Food and Drug Administration (FDA) has approved the PulseSelect Pulsed Field Ablation (PFA) System (Medtronic) for the treatment of both paroxysmal and persistent atrial fibrillation (AF), the manufacturer has announced.